Surani Fernando

Pipeline Report: Several blockbuster drugs are poised to go bigger and broader

Surani Fernando

November 2, 2021

12:00 pm

Therapies in the oncology, neurology and autoimmune disease pipelines could soon pose challenges to existing standards of care.

Pipeline Report 2021: Promising drugs tick along across a range of conditions

Surani Fernando

December 8, 2020

5:00 am

COVID vaccines and therapeutics receive all the headlines — with good reason — but the pharma pipeline is bursting with A-grade candidates across a range of conditions.

Biogen’s touted Alzheimer’s drug receives thumbs-down from FDA advisory panel

Surani Fernando

November 9, 2020

5:00 am

The agency will issue its final verdict on approval in March.

From Our Partners

Partner Content

HCP engagement in 2022 — The HLD HCP Communications Report

Healthlink Dimensions’ 2022 Communications Report — your guide for provider-based insights into HCP marketing outreach as COVID continues to reshape the industry.

Partner Content

Health musings and predictions as we close out 2021

Kim Johnson, Global CEO of Ogilvy Health, sits down with Steve Madden to share her insights on industry developments and challenges over the past year, as well as some thoughts about the unique opportunities for growth in the coming year.

Partner Content

Are more vaccine options the answer for a pandemic-weary public?

For the vaccine hesitant who are still contemplating their first, second or booster doses — or are reluctant to vaccinate their children — perhaps more options would help spur them beyond their hesitations.

Partner Content

Using data signals to understand patient needs

Patients' needs extend beyond their condition — there are multidimensional people behind each diagnosis searching for answers about their interests, hobbies, emotions, lifestyle choices, and more. Now, more than ever, it’s important to find ways to understand consumers as a whole. We can better reach them — and support them — when we do.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Pipeline Report: Several blockbuster drugs are poised to go bigger and broader

Pipeline Report 2021: Promising drugs tick along across a range of conditions

Biogen’s touted Alzheimer’s drug receives thumbs-down from FDA advisory panel

Places to Be 2021

From Our Partners

Partner Content

HCP engagement in 2022 — The HLD HCP Communications Report

Partner Content

Health musings and predictions as we close out 2021

Partner Content

Are more vaccine options the answer for a pandemic-weary public?

Partner Content

Using data signals to understand patient needs

Thank you for accessing MM+M.